▲ Peaking
Business
Moderna and Merck say mRNA cancer vaccine succeeded in late-stage melanoma trial
Moderna and Merck report that a personalized mRNA cancer vaccine succeeded in a late-stage melanoma trial.
Cancer Vaccine
2 trends tracked about this subject — the full history, oldest to newest below.
◼ Archived
Health
🔮 fades ✗
Scientists think they’ve found a new way to stop cancer before it starts
Scientific testing is currently underway on new vaccines designed to intercept hereditary colon and pancreatic cancers.